# ImmunoGenesis Announces Two Publications Highlighting the Potential of IMGS-203, a Novel Stimulator of Interferon Genes (STING) Agonist, to Overcome Tumor Immune Resistance and Enhance Antitumor…

- Source: PR Newswire M&A
- Published: 2026-11-05T17:20:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/immunogenesis-announces-two-publications-highlighting-the-potential-of-imgs-203-a-novel-stimulator-of-interferon-genes-sting-agonist-to-overcome-tumor-immune-resistance-and-enhance-antitumor-efficacy-in-combination-with-a-cyto-302931118.html
- Canonical: https://groundlevelnews.com/story/immunogenesis-announces-two-publications-highlighting-the-potential-of-f42b2b/

HOUSTON, Nov. 5, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced two publications providing new nonclinical evidence and scientific insights into the ability of its novel stimulator of interferon...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._